Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lifschytz

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Molecular Metabolism|August 1, 2025
DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolismDotan Moskovich, Daniel Beilinson, Amit Rosemarin, et al.
Psychopharmacology|September 28, 2011
Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patientsLior Greenbaum, Robert C Smith, Mordechai Lorberboym, et al.
Molecular Psychiatry|September 18, 2013
Neural mechanisms underlying stress resilience in Ahi1 knockout mice: relevance to neuropsychiatric disordersA Lotan, T Lifschytz, A Slonimsky, et al.
Frontiers in Aging Neuroscience|July 4, 2017
Differentially Severe Cognitive Effects of Compromised Cerebral Blood Flow in Aged Mice: Association with Myelin Degradation and Microglia ActivationGilly Wolf, Amit Lotan, Tzuri Lifschytz, et al.
Journal of Neuromuscular Diseases|June 14, 2024
Induced Muscle and Liver Absence of Gne in Postnatal Mice Does Not Result in Structural or Functional Muscle ImpairmentAvi Harazi, Lena Yakovlev, Nili Ilouz, et al.
Life Science Alliance|April 11, 2025
Optogenetic control of pheromone gradients and mating behavior in budding yeastAlvaro Banderas, Maud Hofmann, Céline Cordier, et al.
Journal of Molecular Neuroscience : MN|May 14, 2013
Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory studyLior Greenbaum, Stefano Goldwurm, Polina Zozulinsky, et al.
Oncogene|September 24, 2021
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Oncogene|March 16, 2023
Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Molecular Psychiatry|February 21, 2024
Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brainOrr Shahar, Alexander Botvinnik, Amit Shwartz, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Molecular Metabolism|August 1, 2025
DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolismDotan Moskovich, Daniel Beilinson, Amit Rosemarin, et al.
Psychopharmacology|September 28, 2011
Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patientsLior Greenbaum, Robert C Smith, Mordechai Lorberboym, et al.
Molecular Psychiatry|September 18, 2013
Neural mechanisms underlying stress resilience in Ahi1 knockout mice: relevance to neuropsychiatric disordersA Lotan, T Lifschytz, A Slonimsky, et al.
Frontiers in Aging Neuroscience|July 4, 2017
Differentially Severe Cognitive Effects of Compromised Cerebral Blood Flow in Aged Mice: Association with Myelin Degradation and Microglia ActivationGilly Wolf, Amit Lotan, Tzuri Lifschytz, et al.
Journal of Neuromuscular Diseases|June 14, 2024
Induced Muscle and Liver Absence of Gne in Postnatal Mice Does Not Result in Structural or Functional Muscle ImpairmentAvi Harazi, Lena Yakovlev, Nili Ilouz, et al.
Life Science Alliance|April 11, 2025
Optogenetic control of pheromone gradients and mating behavior in budding yeastAlvaro Banderas, Maud Hofmann, Céline Cordier, et al.
Journal of Molecular Neuroscience : MN|May 14, 2013
Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory studyLior Greenbaum, Stefano Goldwurm, Polina Zozulinsky, et al.
Oncogene|September 24, 2021
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Oncogene|March 16, 2023
Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Molecular Psychiatry|February 21, 2024
Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brainOrr Shahar, Alexander Botvinnik, Amit Shwartz, et al.
Pageof 7